The Prix Galien internationally stands as the industry equivalent of the Nobel Prize.
Initially, the award originated in France, but thanks to the growing dedication of numerous companies to biomedical research and development, this esteemed prize is now granted in 15 different countries.
In Belgium, Artsenkrant/Le Journal du Médecin is the driving force behind the Prix Galien propelling innovation in the Belgian healthcare sector!
2022
Vyvgart®
2021
Trodelvy®
2020
Comirnaty®
2019
Vitrakvi ©
2018
Yescarta® / Kymriah®
2017
Spinraza®
2016
Ibrance®
2015
Opdivo /
Keytruda
2014
Sirturo®
2013
Kadcyla®
2012
Xalkori®
2011
Incivo® &
Victrelis®
2010
Prolia®
2009
Roactemra®
2008
Xarelto®
2007
Lucentis®
2006
Gardasil®
2005
Kepivance®
2004
Velcade®
2003
Fuzeon®
2002
Xigris®
2001
Glivec®
2000
Herceptin®
1999
Vioxx®
1998
MabThera®
1997
Vésanoïd®
1996
Norvir® /
Crixivan®
1995
Betaferon®
1994
Taxol®
1993
Daivonex®
1992
Havrix®
1991
Neupogen®
1990
Zofran®
1989
Zocor®
1988
Eprex®
1987
Fraxiparine®
1986
Engérix B®
1985
Tracrium®
1984
Vectarion® / Hismanal® –
1983
Ciclosporine® / Nizoral®
1982
Zovirax®
2022
KU Leuven
2021
ADDB, LDRI – UCL
2020
LDRI – UCL
2019
Luxembourg Institute of Health
2018
UCLouvain
2017
VUB
2016
Université de Liège
2015
Universiteit Gent
2014
Universiteit Antwerpen
2013
KUL
2012
KUL
2011
KUL
2010
KUL
2009
UCL
2008
KUL
2007
Universiteit Antwerpen
2006
KUL
2005
ULB
2004
KUL
2003
UCL
2002
UCL
2001
ULB
2000
VUB
1999
UCL
1998
ULB
1997
UZ Gent
1996
UCL
1995
ULg
1994
ULg
1993
ULB
1992
UIA
1991
ULB
1990
UIA
1989
Rug
1988
VUB
1987
ULB
1986
ULB
1985
UCL
1984
UCL
1983
–
1982
Hôpital Brugmann
2022
Iriscope
2021
FARAPULSE PHA system®
2020
Granulox®
2019
Rezüm®
2018
Magseed/Magtrace
2017
CPO Detect
2016
Idylla™ NRAS-BRAF
2015
S-ICD EMBLEM®
2022
NAO VNS